Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity

Free Radical Biology and Medicine

Volumn 45, Issue 11, 2008, Pages 1510-1519

  Ansari, Mubeen A ^a   Keller, Jeffrey N ^b   Scheff, Stephen W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Acrolein; Glutathione; Neurodegeneration; Neuroprotection.; Oxidative stress; Pycnogenol

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ACROLEIN; CARBONYL DERIVATIVE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE DISULFIDE; PYCNOGENOL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIPID PEROXIDATION; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEUROPROTECTION; NITRATION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION;

ACROLEIN; ALDEHYDES; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; CYTOTOXINS; FLAVONOIDS; FREE RADICALS; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; LUMINESCENCE; NADPH OXIDASE; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; TYROSINE;

EID: 56049093212     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.08.025     Document Type: Article

References (60)

1. Kondo M., Oya-Ito T., Kumagai T., Osawa T., and Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J. Biol. Chem. 276 (2001) 12076-12083
2. Naoi M., Maruyama W., Shamoto-Nagai M., Yi H., Akao Y., and Tanaka M. Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol. Neurobiol. 31 (2005) 81-93
3. 2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
4. Ansari M.A., Joshi G., Huang Q., Opii W.O., Abdul H.M., Sultana R., and Butterfield D.A. In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders. Free Radic. Biol. Med. 41 (2006) 1694-1703
5. Greenamyre J.T., Betarbet R., and Sherer T.B. The rotenone model of Parkinson's disease: genes, environment and mitochondria. Parkinsonism Relat. Disord. 9 Suppl 2 (2003) S59-64
6. Halliwell B. Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic. Res. 31 (1999) 261-272
7. Mecocci P., MacGarvey U., and Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36 (1994) 747-751
8. Butterfield D.A., Howard B., Yatin S., Koppal T., Drake J., Hensley K., Aksenov M., Aksenova M., Subramaniam R., Varadarajan S., Harris-White M.E., Pedigo Jr. N.W., and Carney J.M. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sci. 65 (1999) 1883-1892
9. Butterfield D.A., Koppal T., Subramaniam R., and Yatin S. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease. Rev. Neurosci. 10 (1999) 141-149
10. Fahn S., and Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32 (1992) 804-812
11. Peng Q.L., Buz'Zard A.R., and Lau B.H. Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis. Brain Res. 104 (2002) 55-65
12. Ueda T., Ueda T., and Armstrong D. Preventive effect of natural and synthetic antioxidants on lipid peroxidation in the mammalian eye. Ophthalmic Res. 28 (1996) 184-192
13. Ahmad A.S., Ansari M.A., Ahmad M., Saleem S., Yousuf S., Hoda M.N., and Islam F. Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol. Biochem. Behav. 81 (2005) 805-813
14. Ahmad M., Saleem S., Ahmad A.S., Yousuf S., Ansari M.A., Khan M.B., Ishrat T., Chaturvedi R.K., Agrawal A.K., and Islam F. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J. Neurochem. 93 (2005) 94-104
15. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23 (1997) 134-147
16. Mercer L.D., Kelly B.L., Horne M.K., and Beart P.M. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem. Pharmacol. 69 (2005) 339-345
17. Paganga G., Miller N., and Rice-Evans C.A. The polyphenolic content of fruit and vegetables and their antioxidant activities. What does a serving constitute? Free Radic. Res. 30 (1999) 153-162
18. Youdim K.A., and Joseph J.A. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic. Biol. Med. 30 (2001) 583-594
19. Duarte J., Perez Vizcaino F., Utrilla P., Jimenez J., Tamargo J., and Zarzuelo A. Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmacol. 24 (1993) 857-862
20. Brown J.P. A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat. Res. 75 (1980) 243-277
21. Kobayashi M.S., Han D., and Packer L. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity. Free Radic. Res. 32 (2000) 115-124
22. Kobuchi H., Virgili F., and Packer L. Assay of inducible form of nitric oxide synthase activity: effect of flavonoids and plant extracts. Methods Enzymol. 301 (1999) 504-513
23. Nardini M., Scaccini C., Packer L., and Virgili F. In vitro inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin-rich pine bark (Pinus marittima) extract. Biochim. Biophys. Acta 1474 (2000) 219-225
24. Packer L., Rimbach G., and Virgili F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic. Biol. Med. 27 (1999) 704-724
25. Siler-Marsiglio K.I., Paiva M., Madorsky I., Serrano Y., Neeley A., and Heaton M.B. Protective mechanisms of pycnogenol in ethanol-insulted cerebellar granule cells. J. Neurobiol. 61 (2004) 267-276
26. Siler-Marsiglio K.I., Shaw G., and Heaton M.B. Pycnogenol and vitamin E inhibit ethanol-induced apoptosis in rat cerebellar granule cells. J. Neurobiol. 59 (2004) 261-271
27. Mello C.F., Sultana R., Piroddi M., Cai J., Pierce W.M., Klein J.B., and Butterfield D.A. Acrolein induces selective protein carbonylation in synaptosomes. Neuroscience 147 (2007) 674-679
28. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11 (1991) 81-128
29. Lovell M.A., Xie C., and Markesbery W.R. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic. Biol. Med. 29 (2000) 714-720
30. Park Y.S., Misonou Y., Fujiwara N., Takahashi M., Miyamoto Y., Koh Y.H., Suzuki K., and Taniguchi N. Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 327 (2005) 1058-1065
31. Kehrer J.P., and Biswal S.S. The molecular effects of acrolein. Toxicol Sci 57 (2000) 6-15
32. Pocernich C.B., and Butterfield D.A. Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox. Res. 5 (2003) 515-520
33. Lovell M.A., Xie C., and Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 22 (2001) 187-194
34. Pocernich C.B., Cardin A.L., Racine C.L., Lauderback C.M., and Butterfield D.A. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem. Int. 39 (2001) 141-149
35. Zhao D.L., Zou L.B., Lin S., Shi J.G., and Zhu H.B. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line. Neuropharmacology 53 (2007) 724-732
36. Nardini M., Finkelstein E.I., Reddy S., Valacchi G., Traber M., Cross C.E., and van der Vliet A. Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid. Toxicology 170 (2002) 173-185
37. McVeigh G.E., Hamilton P., Wilson M., Hanratty C.G., Leahey W.J., Devine A.B., Morgan D.G., Dixon L.J., and McGrath L.T. Platelet nitric oxide and superoxide release during the development of nitrate tolerance: effect of supplemental ascorbate. Circulation 106 (2002) 208-213
38. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97 (1996) 1916-1923
39. Bianca V.D., Dusi S., Bianchini E., Dal Pra I., and Rossi F. beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J. Biol. Chem. 274 (1999) 15493-15499
40. Luo J., Robinson J.P., and Shi R. Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem. Int. 47 (2005) 449-457
41. Luo J., and Shi R. Acrolein induces oxidative stress in brain mitochondria. Neurochem. Int. 46 (2005) 243-252
42. Koppal T., Drake J., Yatin S., Jordan B., Varadarajan S., Bettenhausen L., and Butterfield D.A. Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J. Neurochem. 72 (1999) 310-317
43. Miyamoto Y., Koh Y.H., Park Y.S., Fujiwara N., Sakiyama H., Misonou Y., Ookawara T., Suzuki K., Honke K., and Taniguchi N. Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol. Chem. 384 (2003) 567-574
44. LeWitt P.A. New drugs for the treatment of Parkinson's disease. Pharmacotherapy 20 (2000) 26S-32S
45. Ansari M.A., Ahmad A.S., Ahmad M., Salim S., Yousuf S., Ishrat T., and Islam F. Selenium protects cerebral ischemia in rat brain mitochondria. Biol. Trace Elem. Res. 101 (2004) 73-86
46. Islam F., Zia S., Sayeed I., Zafar K.S., and Ahmad A.S. Selenium-induced alteration of lipids, lipid peroxidation, and thiol group in circadian rhythm centers of rat. Biol. Trace Elem. Res. 90 (2002) 203-214
47. Anderson M.E., and Luo J.L. Glutathione therapy: from prodrugs to genes. Semin. Liver Dis. 18 (1998) 415-424
48. Drake J., Kanski J., Varadarajan S., Tsoras M., and Butterfield D.A. Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J. Neurosci. Res. 68 (2002) 776-784
49. Pocernich C.B., La Fontaine M., and Butterfield D.A. In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem. Int. 36 (2000) 185-191
50. Duweler K.G., and Rohdewald P. Urinary metabolites of French maritime pine bark extract in humans. Die Pharm. 55 (2000) 364-368
51. Virgili F., Pagana G., Bourne L., Rimbach G., Natella F., Rice-Evans C., and Packer L. Ferulic acid excretion as a marker of consumption of a French maritime pine (Pinus maritima) bark extract. Free Radic. Biol. Med. 28 (2000) 1249-1256
52. Uchida K., Kanematsu M., Morimitsu Y., Osawa T., Noguchi N., and Niki E. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 273 (1998) 16058-16066
53. Uchida K., Kanematsu M., Sakai K., Matsuda T., Hattori N., Mizuno Y., Suzuki D., Miyata T., Noguchi N., Niki E., and Osawa T. Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. USA 95 (1998) 4882-4887
54. Luo J., and Shi R. Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem. Int. 44 (2004) 475-486
55. Liu-Snyder P., McNally H., Shi R., and Borgens R.B. Acrolein-mediated mechanisms of neuronal death. J. Neurosci. Res. 84 (2006) 209-218
56. Cao Z., Hardej D., Trombetta L.D., Trush M.A., and Li Y. Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity. Atherosclerosis 166 (2003) 291-301
57. Furuhata A., Nakamura M., Osawa T., and Uchida K. Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduct that covalently binds to thiols. J. Biol. Chem. 277 (2002) 27919-27926
58. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., and Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem. 68 (1997) 255-264
59. Ramachandran V., Watts L.T., Maffi S.K., Chen J., Schenker S., and Henderson G. Ethanol-induced oxidative stress precedes mitochondrially mediated apoptotic death of cultured fetal cortical neurons. J. Neurosci. Res. 74 (2003) 577-588
60. Hah J.M., Roman L.J., and Silverman R.B. Deuterium isotope effects and product studies for the oxidation of N(omega)-allyl-L-arginine and N(omega)-allyl-N(omega)-hydroxy-L-arginine by neuronal nitric oxide synthase. Bioorg. Med. Chem. 8 (2000) 1931-1936